BioWorld MedTech

Sep. 19, 2012

Aptus snags FDA 510(k) for thoracic-length HeliFX

Aptus Endosystems (Sunnyvale, California), a device company developing technology for endovascular aneurysm repair (EVAR), said it has received FDA 510(k) clearance for its thoracic-length HeliFX Aortic Securement System. Read More

Neovasc upbeat about Tiara preclinical study results

International report: Medical Care Technologies signs MOU with Dragon Link

Washington roundup: MHRA wants more frequent follow-up of St. Jude's Riatas

Financings roundup: Health Care REIT in plan to offer up to 22 million shares

Agreements/contracts: Illumina to provide MiSeq to FDA for genome analysis

HIT roundup: Consumers are beginning to comparison shop healthcare

Med-Tech Notes

People in the News

Product Briefs

FDA approves somo-v ABUS system for dense breast tissue

MDD's Oncology Extra

Today's news in brief

BioWorld

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...

Illustration of Alzheimer's disease in the brain

ADPD 2026: Three inflection points to target Alzheimer’s disease

BioWorld Science

A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...